Due to planned maintenance, customers will be unable to make credit card purchases from Sunday midnight to 9 AM Eastern Time, November 23, December 7, and December 14. Thank you for your patience as we continue to improve our infrastructure to better serve you.

Gilead Sciences, Inc.Foster City, CA, United States (NASDAQ (GS): GILD)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Gilead Sciences Financial Statements

Gilead Sciences Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Gilead Sciences Income Statement

  2007 2006 2005
Revenue ($ mil.) 4,230.0 3,026.1 2,028.4
Gross Profit ($ mil.) 3,461.3 2,592.8 1,768.1
Operating Income ($ mil.) 2,164.5 (758.8) 1,111.1
Total Net Income ($ mil.) 1,615.3 (1,190.0) 813.9
Diluted EPS (Net Income) 1.68 (1.29) 0.86
More Gilead Sciences financial information

Gilead Sciences Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 1,278.1 1,258.2 1,094.7
Gross Profit ($ mil.) 1,012.4 1,018.3 879.2
Operating Income ($ mil.) 605.5 668.0 514.5
Total Net Income ($ mil.) 442.8 496.1 401.6
Diluted EPS (Net Income) 0.46 0.51 0.42
More Gilead Sciences financial information

Gilead Sciences Stock Quote & Chart

11/21/08 16:00:04 EST • NASDAQ • 41.46 • Decreased by -0.0700 • Decreased by -0.1686 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Gilead Sciences Financial Ratios

  Company Industry
Median
Market
Median1
Price/Sales Ratio 9.11 3.19 1.45
Price/Earnings Ratio 24.84 14.45 15.11
Price/Book Ratio 11.33 2.53 1.41
Price/Cash Flow Ratio 24.19 12.17 9.14
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Gilead Sciences Financial Ratios

Gilead Sciences Competitive Intelligence

Bristol-Myers Squibb GlaxoSmithKline Roche
Annual Sales ($ mil.) 19,348.0 22,716.0 34,465.2
Employees 42,000 103,401 74,372
Market Cap ($ mil.) 39,993.2 -- --

Competitive Landscape